The mammalian skeletal system harbours a hierarchical system of mesenchymal stem cells, osteoprogenitors and osteoblasts sustaining lifelong bone formation. Osteogenesis is indispensable for the homeostatic renewal of bone as well as regenerative fracture healing, but these processes frequently decline in ageing organisms, leading to loss of bone mass and increased fracture incidence. Evidence indicates that the growth of blood vessels in bone and osteogenesis are coupled, but relatively little is known about the underlying cellular and molecular mechanisms. Here we identify a new capillary subtype in the murine skeletal system with distinct morphological, molecular and functional properties. These vessels are found in specific locations, mediate growth of the bone vasculature, generate distinct metabolic and molecular microenvironments, maintain perivascular osteoprogenitors and couple angiogenesis to osteogenesis. The abundance of these vessels and associated osteoprogenitors was strongly reduced in bone from aged animals, and pharmacological reversal of this decline allowed the restoration of bone mass.
The mammalian skeletal system harbours a hierarchical system of mesenchymal stem cells, osteoprogenitors and osteoblasts sustaining lifelong bone formation. Osteogenesis is indispensable for the homeostatic renewal of bone as well as regenerative fracture healing, but these processes frequently decline in ageing organisms, leading to loss of bone mass and increased fracture incidence. Evidence indicates that the growth of blood vessels in bone and osteogenesis are coupled, but relatively little is known about the underlying cellular and molecular mechanisms. Here we identify a new capillary subtype in the murine skeletal system with distinct morphological, molecular and functional properties. These vessels are found in specific locations, mediate growth of the bone vasculature, generate distinct metabolic and molecular microenvironments, maintain perivascular osteoprogenitors and couple angiogenesis to osteogenesis. The abundance of these vessels and associated osteoprogenitors was strongly reduced in bone from aged animals, and pharmacological reversal of this decline allowed the restoration of bone mass.
Blood vessels mediate the transport of circulating cells, oxygen, nutrients and waste products, but also provide so-called angiocrine signals controlling organ growth and homeostasis [1] [2] [3] [4] . In addition to well-known differences between arteries, capillaries and veins, endothelial cells (ECs) are highly heterogenous and acquire specialized functional properties in local microenvironments 5, 6 . The nature of these specialization processes and the underlying regulation remain largely unknown.
In the mammalian skeletal system, growth of the vascular network is regulated by signals provided by chondrocytes and other bone cells, among which the vascular endothelial growth factor (VEGF) is best understood 7, 8 . Conversely, blood vessels are thought to influence the osteogenic generation of new bone 9, 10 . In addition to earlier studies highlighting the close proximity of vascular and osteoblastic cells, potential roles of angiogenic blood vessel growth in fracture healing have been proposed 11, 12 . It also has been suggested that alterations in the skeletal microvasculature might be linked to compromised haematopoiesis and osteogenesis in human subjects with primary osteoporosis or during old age 13, 14 . However, direct evidence for such disease-causing or age-related alterations is lacking and our understanding of the normal organization, functional specialization and precise function of the skeletal vasculature is incomplete.
Vessel architecture and bone oxygenation
Previous work has shown that molecular and structural differences distinguish arteries and distal arterioles in bone from sinusoidal capillaries [15] [16] [17] [18] . Sinusoidal capillaries form highly branched and irregular networks, and are primarily found between haematopoietic cells within the marrow cavity. Arteries contain comparably few side branches and, as earlier publications 19, 20 have shown, preferentially enter long bone through the femoral or tibial head. The precise overall organization of the skeletal vasculature has remained poorly understood because of technical difficulties associated with the processing of bone combined with the loss of crucial three-dimensional information in thin tissue sections. Revised immunohistochemistry protocols (see Methods) have now allowed us to image the bone vasculature at high resolution. To characterize the organization of arteries, a-smooth muscle actin (a-SMA) staining on thick tibia sections (300 mm) was performed. As proposed previously 19, 20 , straight and smooth muscle cell-covered arteries entered through the bone cortex (Fig. 1a) . The central diaphysis contained few, largely unbranched arteries (diameter 16-27 mm). In contrast, substantial branching was seen in the metaphysis when arteries (diameter 5-15 mm) approached the growth plate (Fig. 1a) , a structure that in small rodents, unlike in humans, persists into adulthood. Some distal arterioles terminated at capillaries in the endosteum (the connective tissue lining the inner surface of compact bone), whereas most termination points were found in the metaphysis near the growth plate (Fig. 1b, c and Extended Data Fig. 1a ). Veins were located in the central diaphysis, connected to metaphyseal capillaries and exited through the cortical bone collar (Extended Data  Fig. 2a) . Thus, arterial oxygen and nutrient-rich blood is preferentially fed into capillaries near the growth plate, which might affect the local metabolic status. Analysis of tibia sections by pimonidazole staining indicated low oxygenation of the diaphysis whereas the metaphysis was not hypoxic (Extended Data Fig. 2b-e) . Likewise, hypoxia-inducible factor 1 a (HIF1-a) immunostaining abundantly labelled cell nuclei throughout the diaphysis and in secondary ossification centres but not in metaphysis (Extended Data Fig. 3a) . The plasma membrane lactate transporter MCT4 (also known as Slc16a3), a hypoxia-regulated protein 21 , and glucose transporter-1 (Glut1), which is induced by HIF signalling and low glucose 22 , were abundant throughout the diaphysis but not in the metaphysis (Extended Data Fig. 3b-d) . Conversely, phosphorylated mitogenactivated protein kinase (phospho-Erk1/2), a marker of cell growth and high metabolic activity 23 , was strongly enriched in metaphyseal cells (Extended Data Fig. 3e ). These data indicate that the spatial distribution of arteries and arteriole-capillary connections determine regional differences in oxygenation and metabolic activity.
Identification of a distinct EC subpopulation in bone
In addition to revised immunofluorescence protocols, we visualized bone vessels by endothelial-cell-specific expression of green fluorescent protein (GFP) in tamoxifen-treated Cdh5(PAC)-CreERT2, Rosa26-mT/mG double transgenic mice 24, 25 . Imaging of the bone microvasculature with both approaches uncovered structurally distinct capillary subsets. Consistent with earlier dye injection and corrosion cast experiments 10, 26 , endothelial tubes in the metaphysis resembled straight columns that were interconnected by distal vessel loops or arches. In contrast, diaphyseal capillaries displayed the highly branched pattern characteristic of the sinusoidal vasculature of bone marrow (Fig. 1d , e and Extended Data Fig. 4a, b) . At the interface between metaphysis and diaphysis, the two vessel types were connected confirming that they were part of one continuous vascular bed (Fig. 1e) . Cdh5(PAC)-CreERT2 and Rosa26-mT/mG double transgenics also validated the endothelial cell specificity of Cre and absence of GFP in chondrocytes, osteoprogenitors, osteocytes or haematopoietic cells (Extended Data Fig. 4c-e) .
The different vessel types were distinguishable by immunostaining with specific cell surface markers. Columnar tubes and arches in the metaphysis and endosteal endothelial cells were strongly positive for CD31 (also known as PECAM1) and Endomucin (Emcn), whereas sinusoidal vessels in the diaphysis displayed only weak CD31 staining and slightly lower Emcn expression ( Fig. 1f and Extended Data Fig. 4f, g) (Fig. 1h) .
These observations established the existence of spatial and phenotypic heterogeneity in the endothelium of long bone, which also applied to other skeletal elements in mice such as vertebra, sternum and calvarium (Extended Data Fig. 5a-d 
Type H endothelium and osteoprogenitor cells
Immunostaining showed that Osterix 1 osteoprogenitors, which will give rise to osteoblasts and osteocytes 27 , were selectively positioned around type H but not type L endothelium (Fig. 2a) . Likewise, collagen type 1a 1 osteoblastic cells and Runx2 1 early osteoprogenitors were abundant around the CD31 1 columns in the metaphysis and CD31 1 endosteal vessels, but essentially absent from the vicinity of diaphyseal type L vessels (Fig. 2b, c) . Despite the low frequency (,1.77%) of type H endothelial cells in the bone endothelial cell fraction and ,0.015% in total bone marrow (Fig. 1g) (Fig. 2d) . Mesenchymal cells expressing platelet-derived growth factor receptor b (PDGFRb) were also preferentially associated with type H vessels in metaphysis and endosteum (Fig. 2e) .
To understand this distribution pattern of osteoblastic cells, the expression of mRNAs for secreted growth factors with known roles in osteoprogenitor survival and proliferation was analysed in freshly purified endothelial cells from long bone. Pdgfa, Pdgfb, Tgfb1, Tgfb3 and Fgf1 transcripts were expressed significantly higher in type H relative to type L endothelial cells (Fig. 3a) . Likewise, quantitative PCR (qPCR) analysis of flushed tibiae retaining the endosteal type H endothelial cells revealed strong enrichment of the same transcripts in comparison to extracted marrow containing type L endothelial cells (Extended Data Fig. 6a, b) . Accordingly, the two bone capillary endothelial cell subsets have specific expression profiles suggesting specialized functional properties.
Loss of type H endothelium during ageing
It has been previously reported that osteoblast numbers decline during ageing 28 . Due to reduced osteogenesis, bone quality and fracture healing potential deteriorate with age, whereas fracture incidences become GFP DAPI gp mp dp α-SMA DAPI gp gp es ep dp mp mp es Endomucin dp mp mp dp Endomucin CD31 DAPI gp mp dp ch 83.23% a-SMA 1 arteries (green) in thick sections (300 mm) of juvenile 4-week-old tibia. Nuclei, DAPI (49,6-diamidino-2-phenylindole, blue). Arteries enter through the cortex (red arrowhead), terminate in endosteum (yellow), and branch in the metaphysis (mp) or diaphysis (dp) (white). Dashed lines mark growth plate (gp) or endosteum (es). b, a-SMA 1 (white) arteries and a-SMA 
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2 arterial branch points; both from four independent experiments). P values, two-tailed unpaired t-tests. d, Representative tile scans of GFP 1 (green) endothelium in juvenile Cdh5(PAC)-CreERT2, Rosa26-mT/mG double heterozygous mouse tibia. Yellow dashed line marks growth plate (gp). Note distinct organization and interconnections (arrowheads) of microvessels in metaphysis (mp) and diaphysis (dp). e, Maximum intensity projections of endothelial cell columns in metaphysis (mp, arrowheads mark distal protrusions), which are connected (arrowheads in central panel) to highly branched sinusoids in diaphysis (dp). RESEARCH ARTICLE more frequent 29 . A remarkable decline in osteoprogenitors was seen in long bone of ageing mice, accompanied by a significant decrease of transcripts for mesenchymal cell and osteoprogenitor markers and the loss of bone mass (Extended Data Fig. 6c-f ). These changes correlated with pronounced reduction of type H vessels, which were much more abundant in juvenile (4-week-old) mice compared to (11-week-old) adults, and were nearly absent in aged (70-week-old) animals ( Fig. 3b and Extended Data Fig. 6c ). Flow cytometry analysis confirmed this age-dependent reduction of CD31 hi Emcn hi endothelial cells, whereas the total endothelial cell number in bone did not change significantly ( Fig. 3c and Extended Data Fig. 6g ). Endothelial cell proliferation was high within the type H subpopulation in juvenile mice and declined rapidly in adulthood ( Fig. 3d and Extended Data Fig. 6h ). In contrast, the rate of type L endothelial cell proliferation did not differ significantly between juvenile and older animals ( 
Type H endothelium mediates neo-angiogenesis in bone
Genetic lineage tracing is a powerful approach for the investigation of cell amplification, differentiation and migration processes 30, 31 . Single injection of 4-week-old Cdh5(PAC)-CreERT2, Rosa26-mT/mG double heterozygotes with a low dose of tamoxifen (see Methods) led to selective green fluorescent protein (GFP) expression in metaphyseal and endosteal type H endothelial cells as well as the endothelium of CD31 1 arteries ( Fig. 4a and Extended Data Fig. 7a ). The analysis of mice at day 40 after tamoxifen administration (at 9.7 weeks of age) revealed profound expansion of the GFP-positive endothelial cells, which were abundant throughout the metaphysis and diaphysis ( Exposure to irradiation is known to induce regression of sinusoidal endothelium, and a transient but substantial decline in endothelial cell number 16 . Flow cytometric quantification at 7 days post-irradiation showed a significant increase in type H endothelial cells and strong reduction of the type L subpopulation (Fig. 4b) . Likewise, immunostaining of tibia sections showed the presence of CD31 hi Emcn hi endothelial cells throughout the diaphysis (Fig. 4b) . These findings are consistent with a role for CD31 hi Emcn hi vessels in developmental and regenerative neo-angiogenesis in bone.
HIF role in angiogenesis and osteogenesis
HIF-1a controls physiological and pathological neo-angiogenesis 34 . In addition to its role in the upregulation of VEGF-A expression in hypoxic tissues, HIF-1a activity in endothelial cells is important for wound healing and tumour angiogenesis in mice 35 . To investigate HIF-1a function in the postnatal bone endothelium, inducible endothelialspecific loss-of-function mice (Hif1a iDEC ) were generated by combining loxP-flanked Hif1a alleles (Hif1a lox/lox ) 35 and Cdh5(PAC)-CreERT2 transgenics. Following tamoxifen administration from postnatal day 10 (P10) to P14, analysis of Hif1a iDEC mutants at P20 revealed striking vascular defects. Whereas the amount of type H endothelium was strongly reduced in metaphysis and endosteum, the number of diaphyseal type L vessels and endothelial cells was comparable to control littermates ( Fig. 4c and Extended Data Fig. 7d, e) .
The von Hippel-Lindau (VHL) E3 ubiquitin protein ligase controls the stability and thereby biological activity of HIF-1a and other substrates 36 . Inducible, endothelial cell specific targeting of the murine Vhl gene with the same strategy as described above for Hif1a led to pronounced expansion of type H endothelium and metaphyseal vessel columns ( Fig. 4d and Extended Data Fig. 7f ). These changes were accompanied by expansion of the metaphysis, increased formation of trabecular (Fig. 5a, b and Extended Data Fig. 7g ). Osteoprogenitors were significantly reduced in Hif1a iDEC samples (Fig. 5c, d ). Likewise, blood alkaline phosphatase levels (a biomarker for osteogenesis) were elevated in Vhl iDEC mutants and reduced in Hif1a iDEC animals (Extended Data Fig. 8a, b) . Histomorphometric analysis and microtomography (m-CT) confirmed increased bone mass in Vhl iDEC mutants without detectable change in calcitonin receptor-positive osteoclasts (Extended Data Fig. 8c-m) . Parathyroid hormone and calcitonin, hormones that regulate bone remodelling, and serum calcium and phosphate levels were not significantly changed in Hif1a iDEC or Vhl iDEC mutants (data not shown).
To understand why endothelial-cell-specific deletion of Hif1a or Vhl primarily affected type H vessels, we analysed HIF-1a expression in 2-week-old bone, which corresponds to the time point of tamoxifen administration. Strong HIF-1a immunostaining was seen in type H but not type L endothelium (Extended Data Fig. 9a) . Furthermore, analysis of freshly isolated type H cells contained significantly higher Hif1a transcript levels than type L endothelial cells (Extended Data Fig. 9b ). Transcripts encoding HIF-1b, which heterodimerizes with HIF-1a, were not significantly different (data not shown). In endothelial cells of adult and ageing animals, Hif1a mRNA was slightly reduced (0.5-fold) but HIF-1a protein was no longer detectable in endothelial cells (Extended Data Fig. 9c, d ), which correlated with the age-dependent loss of type H vessels. Conversely, loss of type L endothelial cells and expansion of CD31 hi Emcn hi endothelium after irradiation (Fig. 4b ) was accompanied by increased HIF-1a expression at both protein and transcript levels (Extended Data Fig. 9e, f) . These findings support a key role of HIF-1a in the induction of type H endothelial cells.
Prolyl-4-hydroxylases (PHDs) modify HIF-1a and thereby mark the protein for degradation under normoxic conditions. Accordingly, PHD inhibitors, such as deferoxamine mesylate (DFM), enhance HIF-1a stability and activity 37 . Treatment of isolated primary bone endothelical cells with DFM led to upregulation of Pecam1 and Emcn transcripts, but also increased the expression of growth factor messenger RNAs that were also enriched in freshly isolated CD31 hi Emcn hi endothelial cells (Fig. 5e ). Next, we tested whether DFM promotes CD31 hi Emcn hi endothelical cells, neo-angiogenesis and osteogenesis in aged animals. Although long bones of aged, 64-to 70-week-old mice treated with vehicle control contained very few CD31 hi Emcn hi vessels, DFM administration (see Methods) led to substantial expansion of type H endothelium ( Fig. 5f and Extended Data Fig. 10a ) and emergence of vessel-associated Osterix 1 cells (Fig. 5g and Extended Data Fig. 10b-d) . Expression levels of osteoprogenitors and osteoblasts markers were significantly increased in long bone and calvarium of DFM-treated animals ( Fig. 5h and Extended Data Fig. 10e ). Furthermore, m-CT examination showed that 6 weeks of DFM treatment led to significantly increased bone mass (Fig. 5i, j) . Although the activity of DFM is not restricted to endothelial cells and is likely to affect multiple cell populations, the findings above argue Genetic lineage tracing d dp dp dp dp dp gp mp dp hi vessels in 4-week-old Cdh5(PAC)-CreERT2, Rosa26-mT/mG tibia at day 1 after tamoxifen administration (left). At day 40, GFP 1 endothelial cells were found throughout the metaphysis (mp) and diaphysis (dp, arrowheads). Nuclei iDEC metaphysis (mp) and expansion in Vhl iDEC samples. Growth plate, gp; diaphysis, dp.
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for crucial roles of endothelial HIF in controlling bone angiogenesis, type H vessel abundance, endothelial growth factor expression and osteogenesis.
Discussion
The mammalian skeleton sustains stem and progenitor cell populations allowing lifelong haematopoiesis and osteogenesis 38, 39 . These processes rely on niche microenvironments for which a number of critical cell types and molecular factors have been identified 40, 41 . In the case of bone formation, mesenchymal stem cells generate new osteoblasts and their progenitors, which are essential for bone homeostasis and fracture healing 42, 43 . Blood vessel growth and the invasion of osteoprogenitors appear coupled in bone fractures 8 but the communication between endothelial and osteoblastic cells remains little understood. Likewise, the exact architecture of the bone vasculature or the processes mediating its growth had remained unknown. Some of these key questions are now resolved in this manuscript. The finding that capillaries in the skeletal system of mice can be subdivided into type H and type L endothelium on the basis of morphological, molecular and functional criteria should be very useful for future studies in basic and medical research. CD31 hi Emcn hi capillaries at the distal end of the arterial network in bone might represent the central building block of a metabolically specialized tissue environment with privileged access to oxygen and nutrients, which probably influences the growth potential and metabolism of other cell types. This is not only relevant for osteoblastic cells but potentially also for haematopoietic stem and progenitor cells, which preferentially home to the metaphysis after transplantation 44 . However, there is also evidence that the bulk of haematopoietic stem cells are exposed to low oxygen, whereas committed and differentiating haematopoietic progenitors reside in relatively well-oxygenated environments 45 . The latter is consistent with our recent description of the hemosphere, a specialized microenvironment found in the mouse metaphysis that enables the clonal expansion of haematopoietic cells 46 . We also propose that type H endothelial cells mediate local growth of the vasculature and provide niche signals for perivascular osteoprogenitors. Type H vessel formation and the expression of potential angiocrine factors for osteoblastic cells are enhanced by HIF and, as we show in the accompanying manuscript 47 , by Notch signalling. Thus, the abundance of CD31 hi Emcn hi endothelial cells may be useful as diagnostic readout for the growth status of the bone vasculature and its pro-osteogenic capacity. Our results also indicate that specific molecular pathways can be used to boost type H vessel formation and osteogenesis (Extended Data Fig. 1b) . This might be of great importance for conditions involving compromised fracture healing or loss of bone mass. Ageing and post-menopausal oestrogen deficiency are major risk factors for osteoporosis 48 , and oestrogen can promote angiogenesis 49 . Accordingly, decline of type H vessels and the concomitant reduction of osteoprogenitor cells could potentially offer a compelling explanation for the loss of bone mass during ageing and might enable therapeutic improvement of osteogenesis in elderly people.
METHODS SUMMARY
Genetically modified and aged mice. C57BL/6J males were used for experiments at the age of 2-4 weeks (juvenile), 8-12 weeks (adult) and 57-70 weeks (aged). Endothelial-cell-specific gene deletions were generated using Cdh5(PAC)-CreERT2 transgenic mice, which were interbred with conditional mutants carrying loxPflanked Hif1a (Hif1a lox/lox ) 35 . To induce Cre activity and gene inactivation, pups were injected with 500 mg tamoxifen (Sigma, T5648) intraperitoneally (i.p.) everyday from P10 to P14. Femurs and tibiae from Cdh5(PAC)-CreERT2 ) controls were collected on P20 or P37 after euthanasia. The same approach was used for experiments involving conditional Vhl mutant mice 50 . For genetic labelling of metaphyseal vasculature,
Cdh5(PAC)-CreERT2
T/1 mice were mated with R26-mG/mT reporters. At P29,
T/1 /R26-mG/mT T/1 mice received a single dose of 50 mg tamoxifen and were analysed either 1 or 40 days later.
All animals were genotyped by PCR. Protocols and primer sequences are provided upon request. When indicated, adult wild-type mice were whole-body irradiated with a single dose of 900 rads (Gammacell irradiator) and euthanized 7 days later.
For DFM treatment, freshly prepared deferoxamine mesylate (Sigma) in water (15 mg ml 21 per mouse) was injected i.p. every other day for 4 weeks or, for m-CT analysis, 6 weeks. Control animals received the same amount of sterile water.
For labelling of proliferating cells, mice were intraperitoneally injected with 1.6 mg per kg weight of EdU (Invitrogen) 2 h before euthanasia. Tibiae were immediately collected and processed. Bone marrow cells and bone sections were stained for EDU using Click-iT chemistry following the manufacturer's instructions (Invitrogen).
Experiments involving animals were performed according to the institutional guidelines and laws, following protocols approved by local animal ethics committees. 
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METHODS
Genetically modified and aged mice. C57BL/6J males were used for experiments at the age of 2-4 weeks (juvenile), 8-12 weeks (adult) and 57-70 weeks (aged). Endothelial-cell-specific gene deletions were generated using Cdh5(PAC)-CreERT2 transgenic mice, which were interbred with conditional mutants carrying loxPflanked Hif1a (Hif1a lox/lox ) 35 . To induce Cre activity and gene inactivation, pups were injected with 500 mg tamoxifen (Sigma, T5648) intraperitoneally (i.p.) everyday from P10 to P14. Femurs and tibiae from Cdh5(PAC)-CreERT2 ) controls were collected on P20 or P37 after euthanasia. The same approach was used for experiments involving conditional Vhl mutant mice 50 . For genetic labelling of metaphyseal vasculature, Cdh5(PAC)-CreERT2
T/1 mice were mated with R26-mG/mT reporters. At P29, double heterozygous Cdh5(PAC)-CreERT2
T/1 /R26-mG/mT T/1 offspring received a single dose of 50 mg tamoxifen and was analysed either 1 or 40 days later.
Experiments involving animals were performed according to the institutional guidelines and laws, following protocols approved by local animal ethics committees. Bone immunohistochemistry. Freshly dissected bone tissues collected from wildtype mice or from mutants and their control littermates were immediately fixed in ice-cold 4% paraformaldehyde solution for 4 h. Decalcification was carried out with 0.5 M EDTA at 4uC with constant shaking and decalcified bones were immersed into 20% sucrose and 2% polyvinylpyrrolidone (PVP) solution for 24 h. Finally, the tissues were embedded and frozen in 8% gelatin (porcine) in presence of 20% sucrose and 2% PVP. For immunofluorescent stainings and morphological analyses, sections were generated using low-profile blades on a Leica CM3050 cryostat.
For phenotypic analysis, mutant and littermate control samples were always processed, sectioned, stained, imaged and analysed together at the same conditions and settings. For immunostaining, bone sections were air-dried, permeabilised for 10 min in 0.3% Triton X-100, blocked in 5% donkey serum at room temperature for 30 min, and probed with the primary antibodies diluted in 5% donkey serum in PBS for 2 h at room temperature (RT) or overnight at 4 uC.
The following primary antibodies were used: Endomucin (sc-65495, Santa Cruz, , and Hif1-a (ab65979, Abcam, 1:100). After primary antibody incubation, sections were washed with PBS for three times and incubated with appropriate Alexa Fluor-coupled secondary antibodies (1:400, Molecular Probes) for 1 h at room temperature. Nuclei were counterstained with DAPI. Sections were thoroughly washed with PBS before mounting them using FluoroMount-G (Southern Biotech). Finally, coverslips were sealed with nail polish.
For metabolic labelling with the hypoxia probe pimonidazole (Pimo, Hypoxyprobe Inc.), mutant and control mice were intraperitoneally injected with 60 mg per kg Pimo for 2 h before euthanasia. Metabolized Pimo was detected by a rabbit antiserum against the non-oxidized, protein-conjugated form of pimonidazole (Hypoxyprobe Inc.). Image acquisition and quantitative analysis. Immunofluorescent stainings were analysed at high resolution with a Zeiss laser scanning confocal microscope, LSM-780. Z-stacks of images were processed and 3D-reconstructed with Imaris software (version 7.00, Bitplane). Imaris, Photoshop and Illustrator (Adobe) software was used for image processing in compliance with Nature's guide for digital images. All quantifications were done with ImageJ, Imaris and Volocity software on highresolution confocal images. Statistical analysis. All data are presented as mean 6 s.e.m. The significance of difference in the mean values was determined using two-tailed Student's t test unless indicated otherwise. P , 0.05 was considered significant. All statistical analysis were performed using GraphPad Prism software. No randomization or blinding was used and no animals were excluded from analysis. Sample sizes were selected on the basis of previous experiments. Several independent experiments were performed to guarantee reproducibility of findings.
Culture of endothelial cells from bone. Tibiae and femurs from wild-type mice or mice expressing endothelial specific reporters (that is, Flk1-GFP 51 and Cdh5(PAC)-CreERT2
) were collected in sterile Ca 21 and Mg 21 free PBS, crushed with mortar and pestle, and digested with collagenase A (Sigma) to obtain a single-cell suspension. Endothelial cells were then MACS sorted using Endomucin antibody (cat. no. SC-65495) and Dynabeads sheep anti-Rat IgG (Invitrogen). Sorted endothelial cells were then plated on dishes coated with fibronectin and cultured in endothelial cell growth medium (EBM-2, Clonetics; Lonza) supplemented with EGM-2 SingleQuots (CC-4176, Clonetic; Lonza). At first passage, cells were again MACS sorted with Endomucin antibody and plated for culture. Cells were fed every third day and passaged upon confluency. Cultures were maintained at 37 uC with 5% CO 2 in a humidified atmosphere. For DFM treatment and subsequent qPCR analysis, endothelial cell cultures between passage 2 and 5 were used. Cells were treated with DFM (6.25 mg ml 21 of culture medium) for the duration of 7 h and subsequently lysed in lysis buffer of RNeasy Mini Kit (Qiagen) for qPCR analysis. Quantitative RT-PCR. For the analysis of mRNA expression levels in type H or type L endothelium, CD31
hi Emcn hi and CD31 lo Emcn lo cells were sorted by FACS directly into the lysis buffer of the RNeasy Mini Kit (Qiagen). Total RNA was isolated according to manufacturer's protocol. A total of 100 ng RNA per reaction was used to generate cDNA with the iScript cDNA Synthesis System (Bio-Rad). Quantitative PCR (qPCR) was performed using TaqMan gene expression assays on ABI PRISM 7900HT Sequence Detection System. The FAM-conjugated TaqMan probes Tgfb1, Tgfb3, Fgf1, Pdgfa, and Pdgfb were used along with TaqMan Gene Expression Master Mix (Applied Biosystems). Gene expression assays were normalized to endogenous VIC-conjugated Actb probes as standard. For analysis of mRNA expression levels from whole bones, dissected femurs were immediately crushed finely, digested with collagenase, centrifuged to obtain a pellet, which was then lysed in lysis buffer of RNeasy Mini Kit (Qiagen). A total of 500 ng RNA per reaction was used to generate cDNA with the iScript cDNA Synthesis System (BioRad), which was further processed as described above. FAM-conjugated TaqMan probes Ibsp, Bglap, Sp7, Cspg4, Pdgfrb, Runx2 and Sp7 were used along with TaqMan Gene Expression Master Mix (Applied Biosystems) to perform qPCR. For the mRNA expression analysis of flushed bone and bone collar/endosteum, FAMconjugated TaqMan probes Tgfb1, Tgfb3, Fgf1, Pdgfa and Pdgfb were used. Gene expression was normalized to the endogenous VIC-conjugated Actb probes. Flow cytometry. For flow cytometric analysis and sorting of type H and type L endothelial cells, tibiae and femurs were collected and cleaned thoroughly to remove the adherent muscles. The epiphysis was removed and only the metaphysis and diaphysis regions were processed. Tibias were then crushed in ice-cold PBS with mortar and pestle. Whole bone marrow was digested with collagenase incubation at 37 uC for 20 min. Equal number of cells were then subjected to immunostaining with endomucin antibody (Santa Cruz, sc-65495) for 45 min. After washing, cells were stained with APC-conjugated CD31 antibody (R&D Systems, FAB3628A) for 45 min. After washing, cells were acquired on BD FACS Canto flow cytometer and analysed using BD FACSDiva software (Version 6.0, BD Bioscience). Cell sorting was performed with FACS Aria II.
For demarcating and sorting CD31 hi Emcn hi endothelial cells, first standard quadrant gates were set, subsequently to differentiate CD31
hi Emcn hi cells from the total double positive cells in quadrant 2 gates were arbitrarily set at .10 4 log Fl-4 (CD31-APC) fluorescence and .10 4 log Fl-2 (Endomucin-PE) fluorescence. For the analysis of total ECs in bone, tibiae were processed as described above to obtain single cell suspensions, which were stained with biotin-coupled CD45 (BD, 553077) or Ter119 (BD, 559971) antibodies for 45 min. After washing in PBS, cells stained with Streptavidin PE-Cy5 (BD, 554062) and Alexa Fluor488-conjugated CD31 (R&D Systems, FAB3628G) antibodies for 45 min. After washing, cells were acquired on a FACS Canto flow cytometer and analysed using FACSDiva software (Version 6.0, BD Bioscience). Total bone ECs were quantified as CD31 . Endomucin was used to distinguish Emcn-negative arterial endothelial cells from Emcn 1 sinusoidal and venous cells. Micro-CT analysis and histomorphometry. Tibiae were collected, and the attached soft tissue was removed thoroughly and fixed in 4% paraformaldehyde. The fixed tibiae were analysed using micro-CT (mCT 35) and software IPL V5.15 at Scanco Medical AG, Switzerland. A voxel size of 12 mm was chosen in all three spatial dimensions. For each sample, 148 from 232 slices were evaluated covering a total of 1.776 mm at a voltage of 70 kVp, intensity 114 mA, integration time 1200 ms.
For calcein double labelling, mice were given intraperitoneal injections of 10mg per kg calcein (Sigma, C0875) dissolved in 2% sodium bicarbonate solution at day 10 and day 3 before euthanasia. Undecalcified bones were fixed in 4% PFA, embedded in 8% gelatin and 2% PVP and cryosectioned. Sections were stained with von Kossa method to assess mineralized bone Osteoclast surface/bone surface (Oc. S/BS; %) and osteoclast number/bone perimeter (No. Oc./B. Pm) were calculated based on Calcitonin receptor staining of bone sections. ARTICLE RESEARCH
